Swan Corp (SWANCORP)

Cyclical

FairStock Score: 4/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹304.6
Market Cap₹9,547.9 Cr
P/E Ratio43.27
ROCE-1.44%
ROE-0.17%
Dividend Yield0.05%
Profit Growth-101.69%
Debt/Equity0.25
Sales Growth-16.4%
Free Cash Flow₹817 Cr
Promoter Holding53.96%
52-Week Range₹273.8 — ₹506
SectorChemicals & Petrochemicals
Book Value₹224.96

Strengths

Concerns

AI Analysis

Let me start with the obvious: a reported P/E of 0.00 is not a bargain; it is an absence of earnings. Swan Corp's latest quarterly net profit is -₹1 Cr on ₹1,150 Cr of sales, and profit growth has collapsed by 101.69%. My first rule is don't lose money; a company earning -0.17% ROE and -1.44% ROCE is destroying value, not compounding it. The petrochemical business is inherently cyclical, and this looks like the downcycle: sales fell 20.49%, and the Piotroski F-score is a weak 2/9. Altman Z of 1.40 puts it in distress territory. When I see EV/EBITDA of 707.13, the market is paying an absurd multiple for almost no operating earnings. The DCF value is -₹0.39, so on cash flows there is no margin of safety. Yet I must be fair. The company is not drowning in debt—D/E is 0.34—and it generated ₹817 Cr of free cash flow even as profits were negative. Promoters own 53.96%, so their interests are aligned with mine. Five-year revenue CAGR of 72.85% proves that in the last upcycle the business grew impressively. But as Buffett says, when management is that good at growing sales, you still need the business to earn more than capital cost. Right now it fails. Book value is ₹234.25, and I am being asked to pay ₹340.95, 1.46 times book, for a cyclically impaired asset with no current earnings. That offers no margin of safety. I would call this a cyclical, not a turnaround, until I see ROCE turn positive and sales stabilize. My circle of competence says: wait for the cycle to turn, then value it on normalized earnings, not today's bottom.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer